Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO^® and OTEMTO^® studies: a subgroup analysis by age

References

• Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2016 Available from: http://www.goldcopd.org/Accessed April 27, 2016
   Google Scholar
• FeenstraTLvan GenugtenMLLHoogenveenRTWoutersEFRutten-van MölkenMPHThe impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the NetherlandsAm J Respir Crit Care Med2001164459059611520721
   PubMed Web of Science ®Google Scholar
• BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
   PubMed Web of Science ®Google Scholar
• RobertsMHMapelDWThomsonHNThe impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary diseaseClinicoecon Outcomes Res2015717318425870513
   PubMedGoogle Scholar
• AnecchinoCRossiEFanizzaCPrevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general populationInt J Chron Obstruct Pulmon Dis20072456757418268930
   PubMedGoogle Scholar
• HoogendoornMHoogenveenRTRutten-van MölkenMPVestboJFeenstraTLCase fatality of COPD exacerbations: a meta-analysis and statistical modelling approachEur Respir J201137350851520595157
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J200219221722411866001
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J200423683284015218994
   PubMed Web of Science ®Google Scholar
• MaltaisFHamiltonAMarciniukDImprovements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPDChest200512831168117816162703
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• BatemanEDTashkinDSiafakasNA one-year trial of tiotropium Respimat® plus usual therapy in COPD patientsRespir Med2010104101460147220620037
   PubMed Web of Science ®Google Scholar
• YohannesAMWillgossTGVestboJTiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomesRespir Care201156447748721255503
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
   PubMed Web of Science ®Google Scholar
• FergusonGTFeldmanGJHofbauerPEfficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studiesInt J Chron Obstruct Pulmon Dis2014962964524966672
   PubMed Web of Science ®Google Scholar
• KochAPizzichiniEHamiltonALung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studiesInt J Chron Obstruct Pulmon Dis2014969771425045258
   PubMed Web of Science ®Google Scholar
• FeldmanGJBernsteinJAHamiltonANivensMCKorduckiLLaForceCThe 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2–4 COPD: results from two 6-week crossover studiesSpring-erplus20143419
   PubMedGoogle Scholar
• LangePAumannJ-LHamiltonATetzlaffKTingNDeromEThe 24 hour lung function time profile of olodaterol once daily versus placebo and tiotropium in patients with moderate to very severe chronic obstructive pulmonary diseaseJ Pulm Respir Med20144196
   Google Scholar
• CazzolaMRoglianiPOraJMateraMGOlodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary diseaseExpert Rev Clin Pharmacol20158552953926294073
   PubMed Web of Science ®Google Scholar
• SinghDFergusonGTBolitschekJTiotropium + olodaterol shows clinically meaningful improvements in quality of lifeRespir Med2015109101312131926320402
   PubMed Web of Science ®Google Scholar
• BuhlRMaltaisFAbrahamsRTiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)Eur Respir J201545496997925573406
   PubMed Web of Science ®Google Scholar
• JonesPWEstimation and application of the minimum clinically important difference in COPDLancet Respir Med20142316716924621674
   PubMed Web of Science ®Google Scholar
• WitekTJJrMahlerDAMinimal important difference of the transition dyspnoea index in a multinational clinical trialEur Respir J200321226727212608440
   PubMed Web of Science ®Google Scholar
• QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJ-CLung volumes and forced ventilatory flowsEur Respir J19936suppl 16540
   PubMed Web of Science ®Google Scholar
• PrideNBAgeing and changes in lung mechanicsEur Respir J200526456356516204583
   PubMed Web of Science ®Google Scholar
• SatohHKagohashiKOharaGUse of tiotropium in patients with COPD aged 80 years and olderExp Ther Med201354997100023596463
   PubMed Web of Science ®Google Scholar
• SchirnhoferLLamprechtBVollmerWMCOPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) StudyChest20071311293617218553
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• LahousseLZiereGVerlindenVJARisk of frailty in elderly with COPD: a population-based studyJ Gerontol A Biol Sci Med Sci201671568969526355016
   PubMed Web of Science ®Google Scholar
• ScanlonPDConnettJEWiseRALoss of bone density with inhaled triamcinolone in Lung Health Study IIAm J Respir Crit Care Med2004170121302130915374846
   PubMed Web of Science ®Google Scholar
• ManninoDMDavisKJKiriVAChronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohortRespir Med2009103222422918945605
   PubMed Web of Science ®Google Scholar
• MolinosLClementeMGMirandaBCommunity-acquired pneumonia in patients with and without chronic obstructive pulmonary diseaseJ Infect200958641742419329187
   PubMed Web of Science ®Google Scholar
• SantusPRadovanovicDDi MarcoSEffect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trialInt J Chron Obstruct Pulmon Dis2015101917192326392766
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence [webpage on the Internet]Chronic Obstructive Pulmonary Disease in over 16s: Diagnosis and Management Clinical Guideline NICE Guidelines [CG101]2010 Available from: http://www.nice.org.uk/guidance/cg101/resources/chronic-obstructive-pulmonary-disease-in-over-16s-diagnosis-and-management-35109323931589Accessed November 18, 2015
   Google Scholar
• American Medical Directors Association (AMDA)COPD Management in the Long-Term Care SettingColumbiaAMDA2010
   Google Scholar